|
| |
Cowen and CompanyCowen and Company's success and growth during the past decade of tumultuous consolidation and change in investment banking is a result of the power of our focus. The company’s foundation of unsurpassed research, trading and investment banking excellence centered around the key sectors of growth in our economy – Health Care, Technology, Media & Telecommunications, Consumer, and Aerospace & Defense– has served us well. Nearly 90 years of successful growth through bull and bear markets is a testament to the recognition that our principal product is knowledge, and meeting the demands of our clients is our first order of business. We are convinced that the fundamental tenets that served us so well in the past century – uncompromising service, time-honored ethics, and a dedication to helping investors capitalize on change – will serve us well in this century.
| Contact Details: |
| 1221 Avenue of the Americas |
| New York |
| New York |
| 10020 |
| United States of America |
| Tel: | (646) 562-1000 |
| Fax: | |
| Email: | Cowen.US-communications@cowen.com |
| WWW: | www.sgcowen.com/

|
|
Loading...
|
Press Releases on Cowen and Company:
|
 |
| Delcath Systems Announces Completion of Public Offering |
18th November, 2009 |
Delcath Systems, Inc. |
NEW YORK, Nov. 18 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH) announced today the closing of its public offering of 9,775,000 shares of common stock priced to the public at $3.60
|
| Pharmos Corporation Reports 2009 Third Quarter Results |
12th November, 2009 |
Pharmos Corporation |
ISELIN, N.J., Nov. 12 /PRNewswire-FirstCall/ -- Pharmos Corporation (Pink Sheets: PARS) today reported financial results for the third quarter and nine-month period ended September 30, 2009.
Third
|
| Delcath Systems, Inc. Announces Public Offering of Common Stock |
27th October, 2009 |
Delcath Systems, Inc. |
NEW YORK, Oct. 27 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH) announced today that it intends, subject to market and other conditions, to offer up to 8.5 million shares of its
|
| Pharmos Corporation Engages Cowen to Assist the Company with Accelerating a Partnership for Dextofisopam |
21st October, 2009 |
Pharmos Corporation |
ISELIN, N.J., Oct. 21 /PRNewswire-FirstCall/ -- Pharmos Corporation (Pink Sheets: PARS); on September 14, 2009, Pharmos announced the results of its Phase 2b Dextofisopam trial for the treatment of
|
| Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing |
1st April, 2009 |
Sunesis Pharmaceuticals, Inc. |
-- Conference Call Scheduled for Today at 5:00 p.m. EDT --
SOUTH SAN FRANCISCO, Calif., April 1 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the execution of
|
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 235 times since April 2007, the link to the organisation's website has been followed 55 times Search for more companies in New York Search for more companies in New York This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Cowen and Company |